A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
Clinical trial NCT04929223 · RECRUITING
Trial details
- NCT number
- NCT04929223
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-22
- Primary completion
- 2030-08-31
- Enrollment
- 542
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.